India pharma giants and global big pharma join forces for NMEs commercialisation in India:…
The focus is on introducing new molecular entities (NMEs) into India, with both parties contributing to accelerate…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
new molecular entities
Growing opportunities in API manufacturing as innovative biologic approvals increase: GlobalData
CMOs can benefit from investing in capabilities and expertise to produce and handle sensitive biologics, as the marketed drugs…
COVID-19 effect will boost infectious disease drug approvals
It will present more opportunities to CMOs informs GlobalData, highlighting that in early May, there were 312 novel pipeline drugs…
Pharma sales to grow beyond $1 trillion
New findings forecast global pharma sales to grow past 2014’s $1 trillion to $1.3 trillion by 2018 The Intellectual Property and…